NEWS

Kostas Tzelepis awarded John Goldman Fellowship

Kostas Tzelepis awarded John Goldman Fellowship

We are delighted to announce that Academic in Residence Kostas Tzelepis has been awarded a John Goldman Fellowship from Leukaemia UK to develop and characterize new drugs against...

Kathryn Lilley awarded EMBO membership

Kathryn Lilley awarded EMBO membership

We are delighted to announce that Kathryn Lilley, Director of the Cambridge Centre for Proteomics, is among 63 leading scientists who have been awarded EMBO membership today -...

Start Codon announces first cohort of companies

Start Codon announces first cohort of companies

Start Codon, the new healthcare accelerator based in the Milner Therapeutics Institute, today announced the first cohort of four companies who were enrolled in the programme this...

Eisai join Milner Therapeutics Consortium

Eisai join Milner Therapeutics Consortium

We are delighted to announce that Eisai have joined the Milner Therapeutics Consortium, which now includes 8 pharma partners. Eisai is a leading global research and...

Milner Institute illuminated blue for the NHS

Milner Institute illuminated blue for the NHS

The Jeffrey Cheah Biomedical Centre illuminated blue tonight, to honour the incredible work of our NHS. Milner Institute Director Professor Tony Kouzarides said "On behalf of...

Milner seminars move online

Milner seminars move online

We have been busy adapting plans for the coming months, and are pleased to announce that our Milner seminars are moving online. The first talk is from Mathew Garnett, and we hope...

Providing COVID-19 support

Providing COVID-19 support

Thank you to the numerous Milner affiliated companies who have been in contact to offer support  to the University and NHS at this time. Help tackle COVID-19 through research...

Milner Institute closure for COVID-19

Milner Institute closure for COVID-19

As part of the response to COVID-19 at the University of Cambridge, the Milner Therapeutics Institute will be closed for non-essential business from Friday March 20th until...

Welcome to the Tzelepis Group

Welcome to the Tzelepis Group

We are delighted that Dr Konstantinos Tzelepis has moved into the Milner Centre for Pathway Analysis as a new Academic in Residence. He brings significant expertise in the...

A look inside the institute

A look inside the institute

For the past four years, the Milner Therapeutics Institute has been incubating in the Gurdon Institute – home to the research lab of our Director Tony Kouzarides. This provided...

Pin It on Pinterest